Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A cochrane review

Human Reproduction Update

Volumn 18, Issue 2, 2012, Pages 111-

  Van Wely, Madelon ^a   Kwan, Irene ^b   Burt, Anna L ^b   Thomas, Jane ^c   Vail, Andy ^d   Van der Veen, Fulco ^a   Al Inany, Hesham G ^e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; RECOMBINANT GONADOTROPIN; UNCLASSIFIED DRUG;

ARTICLE; BIRTH RATE; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN URINE LEVEL; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; PATIENT SAFETY; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL;

FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMANS; OVULATION INDUCTION; PREGNANCY;

EID: 84863399059     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmr048     Document Type: Article

References (0)